Replies to post #91386 on SMART MONEY GROUP

[TheFinalCD]

$CRIS -FDA fast track designation
$KTOV -up 18.6% awaiting FDA P3 news today
$MDGL -Achieves endpoints in Phase 2
$VTVT -licensing deal
$AKS -Imposing tariffs
$VKTX -sQUEEZE

[TheFinalCD]

They did a nice job of shorting it from $187 to $161

The FDA has set a relatively low bar for approval of NASH drugs. I suspect insurers will not be so cooperative. That 23% fibrosis reduction in placebo arm of $MDGL study stands out.

— Adam Feuerstein ✡️ (@adamfeuerstein) May 31, 2018

[TheFinalCD]

good day for mulaaa